KEYNOTE-146: Lenvatinib Plus Pembrolizumab as Early-Line Treatment of Advanced Endometrial Cancer

In this slideset from Clinical Care Options, a panel of international experts review the role of immunotherapy for patients with endometrial cancer.

Mansoor Raza Mirza, MD Bradley J. Monk, MD, FACS, FACOG Prof Isabelle Ray Coquard Released: March 2, 2021

Domenica Lorusso, MD, PhD, on the molecular reclassification of endometrial cancers and key ongoing immunotherapy trials, from Clinical Care Options (CCO)

Domenica Lorusso, MD, PhD Released: February 25, 2021

From Clinical Care Options (CCO), Webcast and downloadable slides reviewing the latest data on the use of PARP inhibitors to treat newly diagnosed advanced ovarian cancer

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci
Program Director Alexandra Leary, MD, PhD Frederik Marmé, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: February 19, 2021 Expired: February 18, 2022

In this slideset from Clinical Care Options, a panel of international experts review the role of immunotherapy for patients with endometrial cancer.

Domenica Lorusso, MD, PhD Mansoor Raza Mirza, MD Ana Oaknin, MD, PhD Released: January 5, 2021